You are here

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Wiener Strasse 50/2
Kapfenberg, , 8605 Austria
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Tick-borne Encephalitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
6-47 months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male and female children aged between 6 and 47 months

- No history of any previous TBE vaccination

- Clinically healthy

- Informed consent provided by the parents

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of allergic reactions, in particular allergic reactions to one of the
components of the vaccine

- Suffering from a disease that cannot be effectively treated or stabilised

- Suffering from a disease or undergoing a form of treatment which can be expected to
influence immunological functions

- Suffering from a chronic, degenerative and/or inflammatory disease of the central
nervous system

- HIV-positivity (no special HIV test required for the purpose of the study)

- Suffering from a febrile disease

- History of vaccination against yellow fever and/or Japanese encephalitis

- Participation in another clinical trial

NCT00161746
Pfizer
Completed
Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now